– CNBC
BTIG Maintains Buy on Omnicell, Lowers Price Target to $160
BTIG analyst David Larsen maintains Omnicell (NASDAQ:OMCL) with a Buy and lowers the price target from $175 to $160.
Related Posts
Tesla Faces Market Share Drop In The UK Despite Rising EV Sales — Model Y Popularity Sees A Dent
EV giant Tesla Inc (NASDAQ:TSLA) saw its market share slump in September as compared to a year ago…
Eli Lilly Makes Largest Manufacturing Investment In Its History To Boost Production For Antidiabetic And Weight Loss Meds
Eli Lilly has significantly increased its investment in its Lebanon, Indiana, manufacturing site to $9 billion, aiming to enhance production of tirzepatide injections.
Elbit Systems Awarded a $120M Contract to Supply Hermes 900 UAS to the Royal Thai Navy
Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems") announced today that it was awarded a contract valued at $120 million to supply Hermes™ 900 Maritime Unmanned Aircraft Systems (UAS) and training capabilities to the Royal Thai Navy. The contract will be performed over a three-year period.